Papillary thyroid carcinoma prevalence and its predictors in patients with primary hyperparathyroidism
Open Access
- 25 September 2022
- journal article
- research article
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 5 (5) , 1499-1504
Abstract
Aim: Papillary thyroid carcinoma (PTC) and primary hyperparathyroidism (PHPT) are among the most common endocrine diseases. Although it has been shown that hyperparathyroidism may be associated with various cancers, the question of whether there is an association between hyperparathyroidism and PTC remains controversial. To evaluate the incidence of concomitant PTC among patients with PHPT and to identify possible risk factors for the development of PTC in these patients. Material and Method: The data of 543 patients who had been operated on due to PHPT in our institution were reviewed retrospectively. Patients who underwent thyroid surgery in conjunction with parathyroidectomy and patients whose diagnosis of PTC was confirmed histopathologically were compared in terms of their clinical, biochemical, and histopathological features. The prevalence of PTC found in patients with PHPT was compared with national rates to estimate standardized incidence ratios (SIRs). Results: Of the 456 PHPT patients enrolled in the study, 281 (61.6%) had concomitant thyroid nodules on thyroid ultrasonography, and PTC was detected in 53 (11.6%) patients during their thyroid surgeries. Compared to the general population, the incidence of papillary thyroid cancer was increased in both women and men with PHPT (SIR: 272.2, 95% CI: 201.6-360.0, pKeywords
This publication has 27 references indexed in Scilit:
- The Accuracy of Thyroid Nodule Ultrasound to Predict Thyroid Cancer: Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2014
- Coincidence of Primary Hyperparathyroidism and Nonmedullary Thyroid CarcinomaHormone and Metabolic Research, 2013
- Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomySurgery, 2008
- Special Variants of Differentiated Thyroid Cancer: Does It Alter the Extent of Surgery Versus Well‐Differentiated Thyroid Cancer?World Journal of Surgery, 2007
- The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomyEndocrine-Related Cancer, 2007
- Preoperative Evaluation of Thyroid Pathology in Patients with Primary HyperparathyroidismThyroid®, 2007
- The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)Cancer Causes & Control, 2005
- Hyperparathyroidism and subsequent cancer risk in DenmarkCancer, 2002
- Parathyroid hormone may be a cancer promoter – an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin DMedical Hypotheses, 2000
- Vitamin D Receptor (VDR) and Parathyroid Hormone Messenger Ribonucleic Acid Levels Correspond to Polymorphic VDR Alleles in Human Parathyroid TumorsThe Journal of Clinical Endocrinology & Metabolism, 1998